Mindray Medical International Limited (迈瑞医疗国际有限公司), the China headquartered medical device maker, reported a 10% increase in revenues during its Q2, largely because China sales jumped 33%. Revenue from the international sales actually dropped 4%. Economic conditions in the US are clearly having an effect on the company’s ex-China sales. Nevertheless, the company handily beat Wall Street estimates. More details...

Stock Symbol: (NYSE: MR)